Akèy › Ensifizans ovè primè › Maryland
Etid klinik pou Ensifizans ovè primè nan Maryland
3 etid pou Ensifizans ovè primè ap chèche patisipan nan sit nan Maryland.
Tèks ofisyèl etid la (Anglè)
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Fanm · Mizajou Sep 28, 2026 · NCT05567198Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 3Volontè an sante akeyi
Laj 11 a 19 · Fanm · Mizajou Sep 18, 2026 · NCT06851754Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)
- National Institutes of Health Clinical Center (Remote and In-Person), Bethesda
- Shady Grove Fertility, Rockville
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Mar 16, 2026 · NCT07357701Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.